Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy

Identifieur interne : 000E33 ( Main/Exploration ); précédent : 000E32; suivant : 000E34

Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy

Auteurs : Angelo Antonini [Italie] ; Patrizia Berto [Italie] ; Stefania Lopatriello [Italie] ; Filippo Tamma [Italie] ; Lieven Annemans [Belgique] ; Mike Chambers [Royaume-Uni]

Source :

RBID : ISTEX:C9F93480604AF95B462D61550F1DC0EDBF1BA469

English descriptors

Abstract

Economic evaluation (Italian NHS perspective) modeling 123I‐FP‐CIT SPECT (DaTSCAN®) compared to clinical judgment alone for differentiating essential tremor (ET) from Parkinson's Disease (PD). A 5‐year Markov model was constructed to assess the cost‐effectiveness of 123I‐FP‐CIT SPECT to differentiate ET from PD in patients referred to a movement disorder specialist in Italy. Published data and a double‐round, Delphi panel of 12 specialists populated the model. Effectiveness was expressed as the projected Years on potentially beneficial therapy (PBTYs). Costs were expressed in Euros (2005 values). The model suggests that over 5 years, the “current” diagnostic pathway generated an average of 2.3 PBTYs/patient at an estimated cost of €8,864. 123I‐FP‐CIT SPECT generated an average of 4.1 PBTYs/patient at an estimated cost of €8,422, which represented an additional 1.8 PBTYs at a cost saving of €442/patient (€341 when discounted at 5%). The estimated cost‐effectiveness of 123I‐FP‐CIT SPECT is under €1,000 per PBTY gained when the underlying disease prevalence is high (55–70%), and cost‐saving at prevalence under 55%. 123I‐FP‐CIT SPECT is likely to be regarded as economically advantageous to differentiate ET from PD, increasing time on potentially beneficial therapy at a lower overall cost to the healthcare system. © 2008 Movement Disorder Society

Url:
DOI: 10.1002/mds.22278


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy</title>
<author>
<name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
</author>
<author>
<name sortKey="Berto, Patrizia" sort="Berto, Patrizia" uniqKey="Berto P" first="Patrizia" last="Berto">Patrizia Berto</name>
</author>
<author>
<name sortKey="Lopatriello, Stefania" sort="Lopatriello, Stefania" uniqKey="Lopatriello S" first="Stefania" last="Lopatriello">Stefania Lopatriello</name>
</author>
<author>
<name sortKey="Tamma, Filippo" sort="Tamma, Filippo" uniqKey="Tamma F" first="Filippo" last="Tamma">Filippo Tamma</name>
</author>
<author>
<name sortKey="Annemans, Lieven" sort="Annemans, Lieven" uniqKey="Annemans L" first="Lieven" last="Annemans">Lieven Annemans</name>
</author>
<author>
<name sortKey="Chambers, Mike" sort="Chambers, Mike" uniqKey="Chambers M" first="Mike" last="Chambers">Mike Chambers</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:C9F93480604AF95B462D61550F1DC0EDBF1BA469</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22278</idno>
<idno type="url">https://api.istex.fr/document/C9F93480604AF95B462D61550F1DC0EDBF1BA469/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001D24</idno>
<idno type="wicri:Area/Main/Curation">001A45</idno>
<idno type="wicri:Area/Main/Exploration">000E33</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy</title>
<author>
<name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Parkinson Institute, Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Berto, Patrizia" sort="Berto, Patrizia" uniqKey="Berto P" first="Patrizia" last="Berto">Patrizia Berto</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>PBE Consulting, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Lopatriello, Stefania" sort="Lopatriello, Stefania" uniqKey="Lopatriello S" first="Stefania" last="Lopatriello">Stefania Lopatriello</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>PBE Consulting, Verona</wicri:regionArea>
<wicri:noRegion>Verona</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tamma, Filippo" sort="Tamma, Filippo" uniqKey="Tamma F" first="Filippo" last="Tamma">Filippo Tamma</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Neurology, San Paolo Hospital, Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Annemans, Lieven" sort="Annemans, Lieven" uniqKey="Annemans L" first="Lieven" last="Annemans">Lieven Annemans</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Department of Public Health, University of Ghent</wicri:regionArea>
<wicri:noRegion>University of Ghent</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chambers, Mike" sort="Chambers, Mike" uniqKey="Chambers M" first="Mike" last="Chambers">Mike Chambers</name>
<affiliation wicri:level="2">
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>GE Healthcare, Chalfont St. Giles</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-11-15">2008-11-15</date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">15</biblScope>
<biblScope unit="page" from="2202">2202</biblScope>
<biblScope unit="page" to="2209">2209</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">C9F93480604AF95B462D61550F1DC0EDBF1BA469</idno>
<idno type="DOI">10.1002/mds.22278</idno>
<idno type="ArticleID">MDS22278</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>123I‐FP‐CIT</term>
<term>DaTSCAN®</term>
<term>Parkinson's disease</term>
<term>Parkinsonism</term>
<term>cost‐effectiveness</term>
<term>essential tremor</term>
<term>single photon emission computed tomography (SPECT)</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="fr">Economic evaluation (Italian NHS perspective) modeling 123I‐FP‐CIT SPECT (DaTSCAN®) compared to clinical judgment alone for differentiating essential tremor (ET) from Parkinson's Disease (PD). A 5‐year Markov model was constructed to assess the cost‐effectiveness of 123I‐FP‐CIT SPECT to differentiate ET from PD in patients referred to a movement disorder specialist in Italy. Published data and a double‐round, Delphi panel of 12 specialists populated the model. Effectiveness was expressed as the projected Years on potentially beneficial therapy (PBTYs). Costs were expressed in Euros (2005 values). The model suggests that over 5 years, the “current” diagnostic pathway generated an average of 2.3 PBTYs/patient at an estimated cost of €8,864. 123I‐FP‐CIT SPECT generated an average of 4.1 PBTYs/patient at an estimated cost of €8,422, which represented an additional 1.8 PBTYs at a cost saving of €442/patient (€341 when discounted at 5%). The estimated cost‐effectiveness of 123I‐FP‐CIT SPECT is under €1,000 per PBTY gained when the underlying disease prevalence is high (55–70%), and cost‐saving at prevalence under 55%. 123I‐FP‐CIT SPECT is likely to be regarded as economically advantageous to differentiate ET from PD, increasing time on potentially beneficial therapy at a lower overall cost to the healthcare system. © 2008 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>Italie</li>
<li>Royaume-Uni</li>
</country>
<region>
<li>Angleterre</li>
<li>Lombardie</li>
</region>
<settlement>
<li>Milan</li>
</settlement>
</list>
<tree>
<country name="Italie">
<region name="Lombardie">
<name sortKey="Antonini, Angelo" sort="Antonini, Angelo" uniqKey="Antonini A" first="Angelo" last="Antonini">Angelo Antonini</name>
</region>
<name sortKey="Berto, Patrizia" sort="Berto, Patrizia" uniqKey="Berto P" first="Patrizia" last="Berto">Patrizia Berto</name>
<name sortKey="Lopatriello, Stefania" sort="Lopatriello, Stefania" uniqKey="Lopatriello S" first="Stefania" last="Lopatriello">Stefania Lopatriello</name>
<name sortKey="Tamma, Filippo" sort="Tamma, Filippo" uniqKey="Tamma F" first="Filippo" last="Tamma">Filippo Tamma</name>
</country>
<country name="Belgique">
<noRegion>
<name sortKey="Annemans, Lieven" sort="Annemans, Lieven" uniqKey="Annemans L" first="Lieven" last="Annemans">Lieven Annemans</name>
</noRegion>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Chambers, Mike" sort="Chambers, Mike" uniqKey="Chambers M" first="Mike" last="Chambers">Mike Chambers</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E33 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000E33 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C9F93480604AF95B462D61550F1DC0EDBF1BA469
   |texte=   Cost‐effectiveness of 123I‐FP‐CIT SPECT in the differential diagnosis of essential tremor and Parkinson's disease in Italy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024